U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07835438) titled 'Transdermal Versus Intralesional Betamethasone for Keloids' on March 24.
Brief Summary: This study aims to evaluate the efficacy and safety of transdermal delivery of compound betamethasone using a medium-frequency device compared with intralesional injection in the treatment of keloids. A total of 45 patients will be enrolled and assigned in a 1:2 ratio to either the intralesional injection group or the transdermal delivery group. Participants will receive three treatment sessions over an 8-week period. Clinical outcomes will be assessed using the Vancouver Scar Scale (VSS), Patient and Observer Scar Assessment Scale (POSAS), and ...